Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lauri Welles, MD
Sanofi-Synthelabo
- Richard A. Gams, MD
Prologue Research International
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Arizona Clinical Research Center
Tucson, Arizona, United States
- California Cancer Care, Inc.
Greenbrae, California, United States
- Valley Tumor Medical Group
Lancaster, California, United States
- Cancer and Blood Institute of the Desert
Rancho Mirage, California, United States
- Rocky Mountain Cancer Centers - Midtown
Denver, Colorado, United States
- Northwestern Connecticut Oncology-Hematology Associates
Torrington, Connecticut, United States
- Lombardi Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Lynn Regional Cancer Center West
Boca Raton, Florida, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Florida Oncology Associates
Jacksonville, Florida, United States
- Hematology and Oncology Consultants, P.A.
Orlando, Florida, United States
- Hematology Oncology Associates of Thetreasure Coast - Port St. Lucie
Port Saint Lucie, Florida, United States
- Palm Beach Cancer Institute
West Palm Beach, Florida, United States
- Peachtree Hematology and Oncology Consultants, P.C.
Atlanta, Georgia, United States
- North Idaho Cancer Center
Coeur d'Alene, Idaho, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Lutheran General Cancer Care Center
Park Ridge, Illinois, United States
- West Suburban Center for Cancer Care
River Forest, Illinois, United States
- Saint Anthony Medical Center
Rockford, Illinois, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Greater Baltimore Medical Center and Cancer Center
Baltimore, Maryland, United States
- Jackson Oncology Associates, Pllc
Jackson, Mississippi, United States
- Veterans Affairs Medical Center - Kansas City
Kansas City, Missouri, United States
- Deaconess Billings Clinic Cancer Center
Billings, Montana, United States
- Cooper Cancer Institute at Cooper University Hospital
Voorhees Township, New Jersey, United States
- Advanced Oncology Associates
Armonk, New York, United States
- North Shore Hematology/oncology Associates, P.C.
East Setauket, New York, United States
- Arena Oncology Associates
Great Neck, New York, United States
- New York University Medical Center
New York, New York, United States
- St. Vincents Comprehensive Cancer Center
New York, New York, United States
- New York Medical College
Valhalla, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Southeastern Medical Oncology Center
Goldsboro, North Carolina, United States
- Physicians East - Quadrangle
Greenville, North Carolina, United States
- Raleigh Hematology/oncology Associates, P.A. - Wake Practice
Raleigh, North Carolina, United States
- Hematology Oncology Consultants Inc
Columbus, Ohio, United States
- Hematology/oncology of Salem
Salem, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2003
- Primary completion
- —
- Completion
- 28 Feb 2011
- Last update posted
- 6 Nov 2013
- Registered enrollment
- —
- Registry id
- NCT00062426
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.